Should an indemnity costs order be made against Mr Hegde?
57 Again, it is appropriate to deal, first, with the indemnity costs order sought by Mark Casey against Mr Hegde. The offer upon which that order is based was contained in a letter dated 26 October 2020 from Mark Casey's lawyers to Mr Hegde's lawyers, as follows:
Without prejudice save as to costs
1. We refer to previous correspondence in this matter, which we note is listed for hearing this Thursday 29 October 2020.
2. We note the following circumstances:
(a) James Dutton's position as a director of Nutricare Holdings Limited (Nutricare [Holdings]) is not under any challenge in the above proceedings.
(b) Mr Hegde's position as a director of Nutricare [Holdings] is in question in the proceedings.
(c) Mr Hegde is challenging the appointment of the four new directors in the proceedings, namely Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon (New Directors).
(d) The majority of shareholders of Nutricare [Holdings] have voted, only two weeks ago, to ratify the appointment of, or appoint, the four New Directors to the Nutricare [Holdings] board.
(e) Nutricare [Holdings] urgently needs confirmation of the composition of its board, so as to be able to finalise its annual accounts and proceed with a capital raise in the next month or so. If it cannot do so, the viability of the business is in jeopardy, to the detriment of all shareholders, as well as [Nutricare Holdings'] employees, contractors and creditors.
(f) If Mr Hegde obtains the relief he seeks in the proceedings, Nutricare [Holdings] will be left with two directors, being Mr Dutton and Mr Hegde. The Nutricare [Holdings] Constitution requires that Nutricare [Holdings] have at least three directors. In the event that their number falls below that minimum, the only action permitted for the remaining director/s is to appoint additional director/s. However, Mr Hegde has acknowledged his difficulty in working with Mr Dutton and it appears that Mr Hegde and Mr Dutton will not be able to agree on any new appointee/s. As a result, if Mr Hegde obtains the relief he seeks in the proceedings, the result will be very damaging, if not disastrous, to Nutricare [Holdings] and its shareholders.
(g) Alternatively, if [Mark Casey] obtains the relief it seeks (whether or not Mr Hegde remains a director) the board can function and the capital raising can proceed, to the benefit of all shareholders. Nutricare [Holdings] will be stabilised, creating the opportunity for the shareholders (if they wish) to make any changes they desire to the composition of the board.
(h) To the extent that there has been irregularity in connection with calling and the conduct of the recent general meeting, it is plainly a procedural irregularity. There has been no substantial injustice. The fact that more than 50% of the shares on issue voted, by proxy, in favour of the resolutions demonstrates that the outcome could not have been changed even if Mr Hegde had not mistaken the start time of the meeting. That level of support also demonstrates that the majority of shareholders were perfectly comfortable in assessing the suitability of the new directors In the period between the notice of and the holding of the meeting.
(i) Particularly in light of the outcome which would flow from the relief sought by Mr Hegde (see paragraphs (e) and (f) above), the basis for curative relief under section 1322 of the Corporations Act 2001 is amply demonstrated.
(j) [Mark Casey] notes the criticisms made by Mr Hegde of Mr Dutton, and by Mr Dutton about Mr Hegde. Insofar as Mr Hegde wishes to see Mr Dutton removed as a director, that is not a matter within [Mark Casey's] power. [Mark Casey] does not have sufficient information about the facts to form a view on either side of the allegations, although it is willing to have the allegations investigated once Nutricare [Holdings] has been stabilised.
(k) [Mark Casey] will not contemplate any resolution to the proceedings which disregards the plainly and recently expressed wishes of the majority of shareholders. It considers that all directors of Nutricare [Holdings] need to be firmly focussed on immediately stabilising the company to raise further capital, which is plainly in the company's best interests. However it seems to [Mark Casey] that Mr Hegde's conduct in continuing to prosecute this case - in his capacity as a shareholder - runs directly contrary to this goal. Mr Hegde's duties as a director (to advance the interests of the company) thus conflict with the effect of his conduct as a shareholder in pursuing this case. In addition, by seeking to remove the four New Directors, Mr Hegde seeks to contradict the clear decision of the shareholders at the EGM on 12 October 2020. While these matters are concerning in the extreme, in recognition of Mr Hegde's substantial shareholding in Nutricare [Holdings], [Mark Casey] is prepared to compromise these proceedings on the basis that Mr Hegde remains on the board - but only on the basis that the status quo is otherwise maintained, such that all other five directors also remain on the board.
(l) In conducting this urgent litigation, [Mark Casey] has to date incurred over $100,000 in costs and disbursements, and expects that figure to rise to over $150,000 by the end of the hearing (both figures excluding GST).
3. Against this background, in a final attempt to put an end to the costs and distraction of these proceedings, we are instructed to confirm that [Mark Casey] is prepared to settle the proceedings on the following terms:
(a) [Mark Casey] will not pursue the line of argument that Mr Hegde is no longer a director of Nutricare [Holdings];
(b) Mr Hegde will not pursue his challenge to the validity of the appointment/ratification of the appointment of the New Directors;
(c) The proceedings be dismissed. As we understand that all other respondents have filed or will have filed submitting appearances, they will be bound by this outcome;
(d) Each of our respective clients bear his or its own costs.
4. This offer is made in accordance with the principles set out in Calderbank v Calderbank [1975] 3 All ER 333. Given that [Mark Casey] is continuing to incur costs on urgent court preparations, this offer will remain open until 1.00pm Sydney time tomorrow 27 November 2020 [sic] and will then lapse.
5. If any aspect of this offer is unclear, please contact the writer. If Mr Hegde considers he requires more time to consider the offer, bearing in mind the imminence of the proceedings and rapidly escalating costs, please contact the writer. If Mr Hegde does not accept this offer and is unsuccessful in the proceedings, [Mark Casey] intends to rely on this letter on the question of costs, including in seeking an order that Mr Hegde pay [Mark Casey's] costs on an indemnity basis.
(Emphasis and errors in original)
58 It can be seen from the terms of this offer that it was expressed to be a Calderbank type offer with possible consequences as to costs (see [57(4) and (5)]). It also contained a relatively detailed explanation of Mark Casey's position in the litigation (see [57(2)]). Finally, it offered Mr Hegde an opportunity to seek an extension of time to respond, or to seek clarification of its terms. While there is no evidence in Mr Rooks' affidavit of Mr Hegde's response to this offer, it appears from the submissions to be common ground that he did not make any response at all.
59 The other document of relevance to this issue is Mark Casey's Concise Statement filed 19 October 2020, particularly "The Relief Sought From The Court" and "The Primary Legal Grounds For The Relief Sought" sections of it. Those sections were in the following terms:
B. THE RELIEF SOUGHT FROM THE COURT
16. [Mark Casey] seeks the following relief, together with an order for its costs:
(a) the dismissal of Mr Hegde's further amended originating application filed on 16 October 2020 with costs;
(b) a declaration that, from at least the time of the circular resolution signed by Mr Dutton on 24 August 2020, or alternatively the general meeting held on 12 October 2020, the Directors of Nutricare Holdings … have been, and remain:
(i) James Dutton, Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon; or
(ii) alternatively, the individuals referred to in paragraph 16(b)(i) immediately above, together with Mr Hegde;
(c) to the extent necessary (if at all) to support the declaration referred to in paragraph 16(b) immediately above, an order under s 1322 of the Corporations Act 2001 (Cth);
(d) Pursuant to s1322(4)(b) of the Corporations Act 2001 (Cth), an order that, within 14 days of these orders, the ASIC register be amended to reflect the declaration referred to in paragraph 16(b) above.
C. THE PRIMARY LEGAL GROUNDS FOR THE RELIEF SOUGHT
17. The resolutions approved at the general meeting on 12 October 2020 were effective to ratify, or made afresh, the appointments of Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon as Directors of Nutricare Holdings … on the following basis:
(a) the power to appoint new Directors to Nutricare Holdings … is not vested by the Constitution exclusively in the Board, but is also exercisable by members at general meeting (cl 8.5);
(b) Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon were eligible for election at the general meeting held on 12 October 2020 by virtue of:
(i) cl 8.5(d) of the Constitution, as they were nominated by a member of Nutricare Holdings…, namely [Mark Casey];
(ii) further or alternatively, cl 8.5(b) of the Constitution, as they had been recommended for election earlier, namely on or around 24 August 2020, by Mr Dutton, then the sole director of Nutricare Holdings …;
(c) to the extent there was not strict compliance with requirements in cl 8.5 of the Constitution, such non-compliance is susceptible to curative relief under s 1322 of the Corporations Act 2001 (Cth), including because:
(i) the irregularity is procedural, has neither caused nor may cause substantial injustice, and did not involve dishonesty;
(ii) it is just and equitable that relief under s 1322 be granted;
(d) the factual matters supporting the grant of such relief under s 1322 in respect of any non-compliance with cl 8.5 of the Constitution include:
(i) the relevant requirement under cl 8.5(d) is the provision of 35 business days' notice, which is procedural in nature, and in practical reality, the shareholders were already informed of the nomination of the four candidates for appointment as Directors by no later than 18 September 2020, if not by 24 August 2020;
(ii) the Board is currently in a state of "deadlock" at a critical juncture in the life of Nutricare Holdings …, where urgent steps need to be taken to raise capital. The appropriate corporate organ to resolve the deadlock is the membership;
(iii) if Mr Hegde forces his short-term views on shareholders against the wishes they have clearly expressed via the outcome of the general meeting on 12 October 2020, the current "deadlock" will likely be resolved as follows:
(A) shareholders will be forced to convene another general meeting in strict compliance with the procedural requirement of 35 business days' notice;
(B) consistent with the views expressed only earlier this month, an overwhelming majority of shareholders will again approve the resolutions appointing the same four individuals as Directors;
(C) because of the need to raise capital at this critical juncture, Nutricare Holdings … will, in the meantime, be exposed to a serious risk of falling under external administration and the loss of shareholders' investments;
(e) in the alternative to the power under cl 8.5 of the Constitution (i.e. paragraphs 17(a)-(d) above), the general meeting had power to pass resolutions approving the appointments of Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon as Directors of Nutricare Holdings … in circumstances where the Board was in a state of "deadlock", either as a matter of general law, or pursuant to cl 11.7 of the Constitution, or both;
(f) contrary to Mr Hegde's contention, there was no irregularity with the time at which the general meeting on 12 October 2020 was held, in that:
(i) the notice of general meeting specified that the meeting would be held in the State of Victoria, being the location of the Principal Place of Business of Nutricare Holdings …, and the reference to 10:00am (EST) would reasonably be understood as 10:00am at the place where the meeting is being held;
(ii) consistent with paragraph 17(f)(i) immediately above, in point of fact:
(A) members of Nutricare Holdings … from Perth, Hong Kong and Los Angeles attended the general meeting at the correct time; and
(B) the only member of Nutricare Holdings … who apparently assumed that the reference to 10:00am was a reference to that time in a place other than where the meeting would be held, was Mr Hegde;
(g) to the extent there was any irregularity with the time at which the general meeting on 12 October 2020 was held:
(i) cl 6.4(a) of the Constitution displaces any conclusion of invalidity;
(ii) it is susceptible to curative relief under s 1322 of the Corporations Act 2001 (Cth), on the basis of the matters referred to at paragraph 17(c)(i) and 17(c)(ii) above;
(iii) the factual matters supporting the grant of relief under s 1322 include:
(A) the attendance of Mr Hegde at the general meeting could not have resulted in a different outcome, because the sheer number of proxy votes in favour of the resolutions meant that the resolutions would have been approved in any event;
(B) Mr Hegde in advance of the general meeting disseminated to members of Nutricare Holdings … an explanatory memorandum setting out in detail his views on the resolutions to be put at the general meeting;
(C) the matters referred to in paragraph 17(d) above.
18. Further or in the alternative to paragraph 17 immediately above, the circulating resolution signed by Mr Dutton on 24 August 2020 was effective to appoint Mark Casey, Mike Tauschek, Hammad Atassi and Kimberlee Boribon as Directors of Nutricare Holdings …, pursuant to cl 8.6(a) and/or cl 11.7 of the Constitution, as Mr Dutton was sole Director at the time.
(Emphasis and errors in original)
60 The principles bearing on this issue have already been outlined above and do not require reiteration. The reasonableness of Mark Casey's offer and the unreasonableness of Mr Hegde's failure to accept it are clearly related concepts. For the reasons that follow, I do not consider Mark Casey's offer met either.
61 First, and most importantly, Mark Casey's offer did not articulate the sole ground upon which it eventually succeeded, namely the reserve power of a company in general meeting to appoint directors where there was a deadlock in the board (see primary judgment at [41]). On this aspect, I do not consider Mark Casey's reliance on [17(b)] of its Concise Statement avails it. Given that was the sole basis for its success and that it endeavoured to provide a detailed explanation for its position in the litigation at [2] of the offer, its presence in the latter and its absence from the former is particularly telling.
62 Secondly, and relatedly, Mark Casey's proposed concession in [3(a)] and the concession it sought from Mr Hegde in [3(b)] of its Concise Statement are both ambiguous. The former obscures the connection between Mr Hegde's currency as a director on 24 August 2020 when the Circulating Resolution was passed and the ratification component of the four resolutions put to the 12 October EGM. It is to be noted that Mark Casey ultimately failed on this issue, namely issue (b) (see the primary judgment at [30]). The latter does not clearly address the main component of the primary relief sought by Mr Hegde in his initial originating application, namely the correction of the ASIC register relating to his directorship from May 2020.
63 In this respect, two things bear noting. First, the explanation at [2] of the offer specifically mentions the former issue (see at [2(d)]), but it does not address the latter. Secondly, at trial, Mark Casey effectively conceded that the ASIC register should be corrected, but sought to keep open the timing of that step in order to pursue its argument with respect to the Circulating Resolution (see primary judgment at [18]).
64 Thirdly, and further to the above, Mark Casey's explanation of its position in the litigation at [2] of the offer is, in my view, complex and confusing. It includes issues that were not raised in its Concise Statement or at trial, for example, Mr Hegde's concern to remove Mr Dutton as a director (see [2(j)]) and does not include issues that were discussed in quite some detail in the Concise Statement itself (see at [59(17)]-[59(18)] above). It also describes in confusing terms issues upon which it ultimately failed at trial, for example, the application of the provisions of s 1322 of the Act to cure the irregularity with respect to the nomination of the four new directors and the primary judgment at [39]-[40]).
65 Fourthly, it appears from the email which attached the letter containing Mark Casey's offer that it was sent at 10.40 pm on 26 October 2020. Paragraph 4 of that letter states: "Given that [Mark Casey] is continuing to incur costs on urgent court preparations, this offer will remain open until 1.00pm Sydney time tomorrow 27 November 2020 [sic] and will then lapse" (emphasis omitted). It can be inferred that Mr Hegde's lawyers read the letter shortly after normal business hours commenced at 9.00 am on 27 October 2020.
66 I interpose to note that the reference to "November" is in error. It was plainly intended to be "October". Accordingly, the "urgent court preparations" referred to the urgent trial in the proceeding which was due to commence on 29 October 2020. Consequently, this exigency applied equally to Mr Hegde. Furthermore, by that time, the vast majority of the costs of the urgent trial were likely to have been incurred.
67 Returning to the offer, since Mr Hegde's lawyers were located in Brisbane and at that time of the year daylight saving operated in New South Wales, 1.00 pm Sydney time equated to 12.00 midday Brisbane time. It follows that the offer remained open for approximately three hours. Even though it offered Mr Hegde the opportunity to seek an extension of that deadline, I do not consider that period was a reasonable period in all the circumstances. Accordingly, I accept Mr Hegde's submission in this respect that his non-acceptance of the offer was not unreasonable.
68 For these reasons, with the exception of (b) which is already mentioned above (at [58]), I do not accept Mark Casey's contentions set out above (at [28]). Specifically, I do not accept that the proposal in [3(a)] and [3(b)] of Mark Casey's offer are equivalent to the outcome it in fact achieved in the primary judgment. Nor do I accept that its offer was clear in its terms, or involved a genuine compromise. That is particularly so with respect to its obfuscation of the connection between issues (a)(i) and (b) on the one part, and issue (c) on the other, concerning the ratification aspect of the 12 October EGM resolutions. It is worth interpolating that this aspect also explains why most, if not all, of the five reasons advanced by Mark Casey above (at [29]) cannot be accepted.
69 Finally, while I accept that Mr Hegde was in a position to assess the merits of the offer, I do not accept that it was reasonable, in the circumstances, to allow him three hours to do so. This provides a separate and independent reason why Mr Hegde's non-acceptance of that offer was not unreasonable.
70 To sum up, for the reasons set out above, I do not consider Mr Hegde's failure to accept Mark Casey's offer constitutes the special or unusual factor necessary to justify an award indemnity costs against Mr Hegde.